The SAFO trial included a substantially smaller number of participants than the Edinburgh and ARREST cohorts, applied more stringent inclusion and exclusion criteria (excluding MRSA infection, moderate to severe heart failure, and IDU), and did not record baseline CRP. Here, CRP is linked to heart failure.